A Pilot Text Messaging Intervention to Reduce Smoking in Office-based Buprenorphine and Inpatient Detoxification Patients

Completed · Not applicable

Conditions studied: Smoking Cessation

In brief

The primary purpose of this study is to understand the feasibility of a text messaging intervention developed by the National Cancer Institute, known as Smokefreetxt, to improve smoking cessation among opiate and/or alcohol dependent participants discharged from an inpatient detoxification unit and enrolled in an office-based buprenorphine program patients (OBBP). Participants will be randomized to 1) treatment as usual (TAU) comprised of informational pamphlets and information for a 1800 quit line; and a prescription for a nicotine replacement therapy (NRT) (i.e. nicotine replacement patches based on the quantity of baseline self-reported smoking, or nicotine replacement gum (2mg) #10, for 28 days which is offered routinely to all inpatients at Bellevue at the time of discharge) versus the SmokeFreeTXT intervention plus prescriptions for NRT.

Key facts

Study ID

NCT02665208

Run by

NYU Langone Health

People needed

203

Starts

2015-03-01

Expected to finish

2017-09-01

Last updated by the study team

2017-12-06

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• self-described every or some day smoker
• diagnosed with opiate dependence and/or alcohol dependence (DSM-IV) per Physician medical records (MISYS)
• Fluency in English and able to provide a written informed consent
• Currently owning a mobile phone with a working phone number
• Expected to reside in the New York City area for the next 12 months
• Understands and able to respond to the intervention text message

You may not qualify if…

• inability to read or understand English
• currently using nicotine replacement therapies (patch, gum, e-cigarettes), pharmacotherapy for smoking cessation such as bupropion (zyban, wellbutrin), varenicline (Chantix).
• suicidal or homicidal ideations
• any ongoing psychotic disorder, life-threatening medical or psychiatric condition
• leaves the inpatient detoxification unit prior to completing study enrollment
• is pregnant, nursing or planning to conceive within the duration of the study period

Where it is running

• New York University School of Medicine — New York, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.